Clinical Outcomes of Dapagliflozin in Acute Heart Failure
Condition: Acute Heart Failure Intervention: Drug: Dapagliflozin 10mg Tab Sponsors: Cairo University; Aswan Heart Centre Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials
Repurposing Empagliflozin and Dapagliflozin for Paediatric Heart Failure: Translational Approach and Dose Rationale
Condition: Heart Failure Interventions: Drug: Dapagliflozin tablet; Drug: Empagliflozin Tablets Sponsors: Centre Hospitalier Universitaire Vaudois; Great Ormond Street Hospital for Children NHS Foundation Trust; University College, London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials
Clinical Outcomes of Dapagliflozin in Acute Heart Failure
Condition: Acute Heart Failure Intervention: Drug: Dapagliflozin 10mg Tab Sponsors: Cairo University; Aswan Heart Centre Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials
Repurposing Empagliflozin and Dapagliflozin for Paediatric Heart Failure: Translational Approach and Dose Rationale
Condition: Heart Failure Interventions: Drug: Dapagliflozin tablet; Drug: Empagliflozin Tablets Sponsors: Centre Hospitalier Universitaire Vaudois; Great Ormond Street Hospital for Children NHS Foundation Trust; University College, London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials
Clinical Outcomes of Dapagliflozin in Acute Heart Failure
Condition: Acute Heart Failure Intervention: Drug: Dapagliflozin 10mg Tab Sponsors: Cairo University; Aswan Heart Centre Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials
Repurposing Empagliflozin and Dapagliflozin for Paediatric Heart Failure: Translational Approach and Dose Rationale
Condition: Heart Failure Interventions: Drug: Dapagliflozin tablet; Drug: Empagliflozin Tablets Sponsors: Centre Hospitalier Universitaire Vaudois; Great Ormond Street Hospital for Children NHS Foundation Trust; University College, London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials
Clinical Outcomes of Dapagliflozin in Acute Heart Failure
Condition: Acute Heart Failure Intervention: Drug: Dapagliflozin 10mg Tab Sponsors: Cairo University; Aswan Heart Centre Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials
